Temáticas asociadas a la vacunación contra COVID-19 en el 2021. Una revisión rápida
DOI:
https://doi.org/10.61182/Palabras clave:
Vacunación, COVID-19, Social, Salud, PolíticaResumen
Antecedentes: el síndrome respiratorio agudo severo coronavirus 2 (SARS-CoV-2) es el virus responsable de la pandemia mundial de la enfermedad por COVID-19. Objetivo: describir los diferentes aspectos derivados de la vacunación contra el COVID-19 a nivel general abordados en la literatura científica durante el 2021.
Métodos: tras una búsqueda en inglés en Pubmed, se seleccionaron 40 artículos.
Resultados: desde la literatura científica, se abordaron múltiples aspectos asociados a la vacunación contra el COVID-19 en el plano social, político-económico, salud y efectos posvacunación.
Conclusiones: en 2021, la preocupación por el desarrollo de una vacuna segura ha dado paso a la reticencia a la vacunación contra el COVID-19, la desigualdad en su distribución y priorización y los efectos generados después de su aplicación.
Referencias
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 2020;382(8):727-33.
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9.
Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China. JAMA. 2020;323(8):709.
Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615-32.
Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584(7821):437-42.
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report. New England Journal of Medicine. 2020;383(20):1920-31.
Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. New England Journal of Medicine. 2021;384(15):1412-23.
Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. New England Journal of Medicine. 2021;384(23):2187-201.
Thomas SJ, Moreira ED, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. New England Journal of Medicine. 2021;385(19):1761-73.
Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586(7830):567-71.
Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830):594-9.
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626-36.
Song S, Zhou B, Cheng L, Liu W, Fan Q, Ge X, et al. Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice. Virol J. 2022;19(1):2.
Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med. 2021;27(2):205-11.
Roura AM. BBC. 2021 [citado 12 de agosto de 2021]. Cómo se convirtió Chile en el líder de la vacunación contra la covid-19 de América Latina. Disponible en: https://www.bbc.com/mundo/noticias-america-latina-56267103
Our world in data. Our world in data. [citado 17 de febrero de 2022]. Coronavirus (COVID-19) Vaccinations. Disponible en: https://ourworldindata.org/covid-vaccinations#citation
Organización Panamericana de la Salud. OPS. 2020 [citado 17 de enero de 2022]. Acceso a la vacuna contra el COVID-19 mediante el mecanismo COVAX. Disponible en: https://www.paho.org/es/noticias/5-10-2020-acceso-vacuna-contra-covid-19-mediante-mecanismo-covax
Díaz Pinzón JE. Cobertura de vacunación contra COVID-19 por esquema en Colombia. Revista Repertorio de Medicina y Cirugía. 2021;30(1):114-7.
Biswas N, Mustapha T, Khubchandani J, Price JH. The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers. J Community Health [Internet]. 2021 [citado 4 de enero de 2022];46(6):1244-51. Disponible en: https://doi.org/10.1007/s10900-021-00984-3
Al‐Amer R, Maneze D, Everett B, Montayre J, Villarosa AR, Dwekat E, et al. COVID‐19 vaccination intention in the first year of the pandemic: A systematic review. J Clin Nurs [Internet]. 2021 [citado 2 de febrero de 2022];31(1-2):62-86. Disponible en: https://doi.org/10.1111/jocn.15951
Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors. Prev Med (Baltim) [Internet]. 2021 [citado 12 de febrero de 2022];150:106694. Disponible en: https://doi.org/10.1016/j.ypmed.2021.106694
Khubchandani J, Macias Y. COVID-19 vaccination hesitancy in Hispanics and African-Americans: A review and recommendations for practice. Brain Behav Immun Health [Internet]. 2021 [citado 12 de febrero de 2022];15:100277. Disponible en: https://doi.org/10.1016%2Fj.bbih.2021.100277
Olusanya OA, Bednarczyk RA, Davis RL, Shaban-Nejad A. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic. Front Immunol. 2021;12.
Eberhardt CS, Siegrist C. Is there a role for childhood vaccination against COVID‐19? Pediatric Allergy and Immunology [Internet]. 2021 [citado 12 de febrero de 2022];32(1):9-16. Disponible en: https://doi.org/10.1111/pai.13401
Evans WD, French J. Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing. Vaccines (Basel) [Internet]. 2021 [citado 12 de febrero de 2022];9(4):319. Disponible en: https://doi.org/10.3390/vaccines9040319
Rzymski P, Borkowski L, Drąg M, Flisiak R, Jemielity J, Krajewski J, et al. The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation. Vaccines (Basel) [Internet]. 2021 [citado 12 de febrero de 2022];9(2):109. Disponible en: https://doi.org/10.3390/vaccines9020109
Brüssow H. COVID-19: vaccination problems. Environ Microbiol. 2021;23(6):2878-90.
Sarwal Y, Sarwal T, Sarwal R. Prioritizing pregnant women for COVID‐19 vaccination. International Journal of Gynecology & Obstetrics. 2021;155(1):57-63.
Gianfredi V, Pennisi F, Lume A, Ricciardi GE, Minerva M, Riccò M, et al. Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature. Vaccines (Basel). 2021;9(6):574.
Afolabi MO, Wariri O, Saidu Y, Otu A, Omoleke SA, Ebenso B, et al. Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis. BMJ Glob Health [Internet]. 2021 [citado 13 de febrero de 2022];6(12):e007518. Disponible en: https://doi.org/10.1136/bmjgh-2021-007518
Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health Journal. 2021;5(1):51-5.
Kumar VM, Pandi-Perumal SR, Trakht I, Thyagarajan SP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. NPJ Vaccines. 2021;6(1):60.
Campos-Matos I, Mandal S, Yates J, Ramsay M, Wilson J, Lim WS. Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK. The Lancet Regional Health - Europe. 2021;2:100021.
Pasquale S, Gregorio GL, Caterina A, Francesco C, Beatrice PM, Vincenzo P, et al. COVID-19 in Low- and Middle-Income Countries (LMICs): A Narrative Review from Prevention to Vaccination Strategy. Vaccines (Basel) [Internet]. 2021 [citado 12 de febrero de 2022];9(12):1477. Disponible en: https://doi.org/10.3390/vaccines9121477
Sheikh AB, Pal S, Javed N, Shekhar R. COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation. Infect Dis Rep. 2021;13(2):429-36.
Das KP, Sharma D, Saha S, Satapathy BK. From outbreak of COVID-19 to launching of vaccination drive: invigorating single-use plastics, mitigation strategies, and way forward. Environmental Science and Pollution Research. 2021;28(40):55811-45.
Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, et al. Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience. Journal of the European Academy of Dermatology and Venereology. 2022;36(2):172-80.
Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerg Infect Dis. 2021;27(12):3175-8.
Lee KA, Kim YJ, Jin HY. Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine. 2021;74(3):470-2.
Katsikas Triantafyllidis K, Giannos P, Mian IT, Kyrtsonis G, Kechagias KS. Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports. Vaccines (Basel). 2021;9(9):1013.
Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M. Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review. Acad Radiol. 2021;28(8):1058-71.
Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci. 2021;428:117607.
Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences. 2021;43(1):3-40.
Al‐Ali D, Elshafeey A, Mushannen M, Kawas H, Shafiq A, Mhaimeed N, et al. Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review. J Cell Mol Med. 2022;26(3):636-53.
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, et al. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis. Eur J Cancer. 2021;160:243-60.
Sakuraba A, Luna A, Micic D. Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis. Gastroenterology. 2021;162(1):88-108.e9.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, et al. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf. 2021;44(12):1247-69.
Furer V, Rondaan C, Agmon-Levin N, van Assen S, Bijl M, Kapetanovic MC, et al. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. RMD Open. 2021;7(1):e001594.
Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, et al. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Lancet Haematol. 2021;8(12):e934-46.
Pal R, Bhadada SK, Misra A. COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(2):505-8.
Mazereel V, Van Assche K, Detraux J, De Hert M. COVID-19 vaccination for people with severe mental illness: why, what, and how? Lancet Psychiatry. 2021;8(5):444-50.
Jorgensen SCJ, Burry L, Tabbara N. Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2021;42(1):58-70.
Januszek SM, Faryniak-Zuzak A, Barnaś E, Łoziński T, Góra T, Siwiec N, et al. The Approach of Pregnant Women to Vaccination Based on a COVID-19 Systematic Review. Medicina (B Aires). 2021;57(9):977.
Andryukov BG, Besednova NN. Older adults: panoramic view on the COVID-19 vaccination. AIMS Public Health. 2021;8(3):388-415.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2024 Yuly Paola Rojas Rojas, Jorge Enrique Díaz Pinzón, Jaime Arturo Cabrera Navarrete
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Cómo citar
